Latest article
Sort 2 diabetes missed or prognosis delayed for 60,000 UK folks in 2020
Researchers studying the effects of COVID-19 on the NHS in the UK reviewed the health records of 14 million people between March and December...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
15 comfortable Amazon necessities to deal with your self to this fall
If you had to take off your winter coat for the first time in a long time last week, the reality is probably right...